PHASE-2 TRIAL OF RECOMBINANT ALPHA-2B-INTERFERON AND LOW-DOSE CYCLOPHOSPHAMIDE IN ADVANCED MELANOMA AND RENAL-CELL CARCINOMA

被引：24

作者：

WADLER, S ^{[1
]}

EINZIG, AI ^{[1
]}

DUTCHER, JP ^{[1
]}

CIOBANU, N ^{[1
]}

LANDAU, L ^{[1
]}

WIERNIK, PH ^{[1
]}

机构：

[1] ALBERT EINSTEIN CANC CTR, BRONX, NY USA

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1988年 / 11卷 / 01期

关键词：

D O I：

10.1097/00000421-198802000-00012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：55 / 59

页数：5

共 22 条

[1]

BALKWILL FR, 1984, CANCER RES, V44, P904

[2]

CARMICHAEL J, 1986, CANCER RES, V46, P4916

[3]

CREAGAN ET, 1984, CANCER, V54, P2844, DOI 10.1002/1097-0142(19841215)54:12<2844::AID-CNCR2820541205>3.0.CO

[4]

2-Q

[5]

CUPPS TR, 1982, J IMMUNOL, V128, P2453

[6] EFFICACY OF COMBINED INTERFERON CYCLOPHOSPHAMIDE THERAPY AFTER DIAGNOSIS OF LYMPHOMA IN AKR MICE [J].

GRESSER, I ;

MAURY, C ;

TOVEY, M .

EUROPEAN JOURNAL OF CANCER, 1978, 14 (01) :97-99

[7]

HARRIS DT, 1983, SEMIN ONCOL, V10, P422

[8] COMPARISON OF INTRAMUSCULAR AND INTRAVENOUS RECOMBINANT ALPHA-2 INTERFERON IN MELANOMA AND OTHER CANCERS [J].

KIRKWOOD, JM ;

ERNSTOFF, MS ;

DAVIS, CA ;

REISS, M ;

FERRARESI, R ;

RUDNICK, SA .

ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :32-36

[9]

KROWN SE, 1987, CANCER TREAT REP, V71, P39

[10]

KROWN SE, 1987, CANCER, V59, P647, DOI 10.1002/1097-0142(19870201)59:3+<647::AID-CNCR2820591313>3.0.CO

← 1 2 3 →